Anavex Life Sciences Corp (AVXL)

[poguemahone]

Falconer:

It seems like you’re hedging your bet a bit on A2-73’s effectiveness with stabilizing or improving cognitive decline in ALZ by stating that better sleep might be enough to gain acceptance and approval. Perhaps, but that is at best a secondary endpoint, and one which will be immediately dismissed by many skeptics as “data mining.” We need cognitive improvement or stabilization—anything else is just a door prize.

BTW, should we not be expecting some trial enrollment updates, or is DM too busy coloring Easter eggs?